Flynn, John - Johns Hopkins University

个人简介

Dr. Flynn completed his undergraduate work at Boston College, graduating magna cum laude with a B.A. in Mathematics. Dr. Flynn received his MD from the University of Missouri-Columbia and completed his internship and residency at The Johns Hopkins University School of Medicine, followed by a fellowship in rheumatology. Dr. Flynn also completed his MBA at The Johns Hopkins University and his MEd at the University of Cincinnati. He is Board certified in internal medicine and rheumatology and is a fellow with the American College of Rheumatology and the American College of Physicians. He is a member of the Assessment of Spondyloarthritis international Society (ASAS). The mission of this international group of experts in the field of spondyloarthritis to support and promote the study of Axial and Peripheral Spondyloarthritis, Increasing awareness and early diagnosis of the disease, the development and validation of assessment tools, and the evaluation of treatment modalities in order to promote clinical research with the ultimate goal to improve outcome of the disease. He is also a member of the Spondyloarthritis Research and Treatment Network’ (SPARTAN). This a network of health care professionals in North America who are dedicated to research, awareness and treatment of spondyloarthritis. His research focuses on Innovations in ambulatory medical education, electronic medical records and the advancement of care for patients with spondyloarthritis. Dr. Flynn is the editor and co-author of Cutaneous Medicine: Cutaneous Manifestations of Systemic Disease, the Oxford American Handbook of Clinical Medicine, and Mosby’s Guide to Physical Examination. MD, University of Missouri Columbia School of Medicine (1986)

研究领域

Care of patients with spondyloarthritis; ambulatory education; delivery of primary care in an academic setting; Arthritis

近期论文

查看导师最新文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Zeidler RB, Flynn JA, Arnold JC, Conley NS. Subpopulation of alveolar macrophages inhibits superoxide anion production by macrophages. Inflam. 1987;11(3):371-379. Esolen LM, Fasano MB, Flynn JA, Burton A, Lederman HM. Brief Report: pneumocystis carinii osteomyelitis in a patient with common variable immunodeficiency. NEJM. 1992;326(15):999-1001. Flynn JA, Hellmann DB. Methotrexate in rheumatoid arthritis: when nsaids fail. Cleveland Clin J of Med. 1995;62(6):351-359. Flynn JA, Wigley FM. Musculoskeletal and rheumatic diseases common to the elderly. Clinical Aspects of Aging, 4th Edition, 1995;308-325. Hellmann DB, Flynn JA. New ways to teach general internal medicine: the role of ambulatory subspecialty rotations. Trans Am Clin Climatol Assoc. 1996;108:259-267. Flynn JA, Hellmann DB. Giant cell arteritis and cerebral vasculitis. Current Therapy in Neurological Diseases, 5th Edition, 1997;214-220. Silverman IE, Flynn JA. Ivory Vertebra. NEJM. 1998;338(2):100. Hellmann DB, Flynn JA. The clinical presentation and natural history of Takayasus arteritis and other inflammatory arteritides. Vascular Intervention: A Clinical Approach, 1998;249-256. Flynn JA, Rompalo AM. Selected spirochetal infections: syphilis and lyme disease. Principles in Ambulatory Medicine, 5th Edition, 1999;372-385. Ling S, Flynn JA, Wigley FM. Musculoskeletal diseases in care of the elderly. Clinical Aspects of Aging, 5th Edition, 1999;367-390. Hellmann DB, Flynn JA. Development and evaluation of a coordinated, ambulatory rheumatology experience for internal medicine residents. Arthritis Care and Res. 1999;12(5):325-330. Danoff S, Grasso M, Terry P, Flynn JA. Pleuropulmonary disease due to Pergolide use for restless leg syndrome. Chest. 2001;120(1):313-316. Hoffman GS, Cid MC, Hellmann DB, Guillevin L, Stone JH, Schousboe J, Cohen P, Calabrese LH, Dickler H, Merkel PA, Fortin P, Flynn JA, Locker GA, Easley KA, Schned E, Hunder GG, Sneller MC, Tuggle C, Swanson H, Hernandez-Rodriguez J, Lopez-Soto A, Bork D, Hoffman DB, Kalunian K, Klashman D, Wilke WS, Scheetz RJ, Mandell BF, Fessler BJ, Kosmorsky G, Prayson R, Luqmani RA, Nuki G, McRorie E, Sherrer Y, Baca S, Walsh B, Ferland D, Soubrier M, Choi HK, Gross W, Segal AM, Ludivico C, Puechal X. A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis. Arthritis & Rheumatism. 2002;46(5):1309-1318. Gress TW, Flynn JA, Rubin HR, Simonson L, Sisson S, Thompson T, Brancati FL. Effect of student involvement on patient perceptions of ambulatory care visits: a randomized controlled trial. JGIM. 2002;17:420-427. Flynn JA, Auwaerter PG. Lyme disease and other tickborne illnesses. Principles of Ambulatory Medicine, Sixth Edition, 2003;498-507. Beste LA, Ansari-Lari A, Borowitz M, Flynn JA. Lymphadenopathy, cough, and fever in a 51-year-old woman with systemic lupus erythematosus: case report of lymphomatoid granulomatosis. Arthr Care & Res, 2005;53(4):621-624. Desai MY, Santos RD, Dalal D, Carvalho JA, Martin DR, Flynn JA, Nasir K, Blumenthal RS. Relation of serum uric acid with metabolic risk factors in asymptomatic middle-aged Brazilian men. Am J of Card. 2005;95(7):865-868. Flynn JA, Latif O. Clinical images in medicine: Superior mesenteric artery syndrome. Johns Hopkins Advanced Studies in Medicine, 2006;6(1):494. Nguyen J, Marinopoulos SS, Ashar BH, Flynn JA. Clinical problem-solving: More than meets the eye. NEJM, 2006;355(10):1048-1052. Flynn JA, Arnett FC. Ankylosing spondylitis. Principles of Ambulatory Medicine, Seventh Edition, 2006, 1280-1290. Auwaerter PG, Flynn JA. Lyme disease and other tickborne illnesses. Principles of Ambulatory Medicine, 2006, 560-570. Flynn JA. Rheumatology and musculoskeletal conditions. Oxford American Handbook Of Clinical Medicine, 2007;362.379. Flynn JA (ed.), Oxford American Handbook of Clinical Medicine, Oxford University Press, New York, 2007. Martin DR, Schlott DW, Flynn JA. Clinical problem-solving: No respecter of age. NEJM, 2007;357(18):58-61. van der Heijde D, Schiff M, Sieper J, Flynn JA, (ATLAS Study Group). Adalimumab treatment maintains efficacy and safety in patients with ankylosing spondylitis (AS): 2-Year results from ATLAS. Presentation at European League Against Rheumatism (EULAR), Barcelona, Spain, June 2007.